Polymer Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,625
Closed -$176K 960
2025
Q4
$176K Buy
+13,625
New +$175K 0.02% 704
2025
Q1
Sell
-6,989
Closed -$208K 577
2024
Q4
$208K Buy
+6,989
New +$148K 0.06% 295

Other funds holding NVCR

Polymer Capital Management's NVCR Position: Q1 2026 in Review

Polymer Capital Management sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 13,625 shares — an estimated $176K sold.

Polymer Capital Management first reported a position in NVCR in Q4 2024 and held it in 2 quarters. The position peaked at $208K in Q4 2024. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Polymer Capital Management reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Polymer Capital Management sold 13,625 NovoCure shares in Q1 2026, an estimated $176K.
  • Polymer Capital Management first reported a position in NovoCure in Q4 2024 and held it in 2 quarters.
  • Polymer Capital Management's NovoCure position peaked at $208K in Q4 2024.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.